Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations

Pharmacoepidemiology and Drug Safety
C R DrinkardJ Clouse

Abstract

This retrospective surveillance study used linked administrative claims data and medical records to determine the rate and types of birth malformations in infants born to women exposed to the antibiotic, clarithromycin (Biaxin), during the first trimester of pregnancy. Pharmacy and hospital claims from eight geographically diverse health plans were used to identify women who had a delivery claim within 270 days of a clarithromycin prescription over a 5-year period (1991-1995). Hospital delivery admission medical records for 143 mothers and their 149 infants were abstracted to identify birth malformations. Five infants were identified with major malformations, three with minor malformations, and four with undescended testicles likely to resolve with time. The observed rate of 3.4% (95% CI, 0.5, 6.3) for major malformations was not statistically significantly different compared to an expected rate of 2.8% based on earlier national data. There was no consistency across types of major malformations. These results provide no evidence that clarithromycin is a likely major teratogen in humans. Use of claims data is one way to evaluate quickly and efficiently the safety of prescription medications in humans during pregnancy, especially...Continue Reading

References

Feb 1, 1991·The Journal of Antimicrobial Chemotherapy·H C Neu
Nov 1, 1988·American Journal of Obstetrics and Gynecology·J M PiperP Price
Apr 1, 1989·American Journal of Epidemiology·W A Ray, M R Griffin
Jul 1, 1987·American Journal of Epidemiology·M J Khoury, N A Holtzman
Jan 1, 1994·Journal of Clinical Epidemiology·A D McDonald
Apr 1, 1993·American Journal of Epidemiology·J M PiperP Taylor
Jan 1, 1996·Paediatric and Perinatal Epidemiology·G S Berkowitz, R H Lapinski
Apr 17, 1998·The New England Journal of Medicine·G KorenS Ito

❮ Previous
Next ❯

Citations

Dec 18, 2001·Prenatal Diagnosis
Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Mar 1, 2003·Clinics in Dermatology·Noah S ScheinfeldJeffrey M Weinberg
Apr 10, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sonya ShinJennifer Furin
May 8, 2013·Antimicrobial Agents and Chemotherapy·Anat Bahat DinurAmalia Levy
Oct 17, 2009·Expert Opinion on Drug Safety·Matteo CassinaMaurizio Clementi
Jun 19, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Benjamin Bar-OzMatitiahu Berkovitch
Oct 30, 2015·Pharmacoepidemiology and Drug Safety·Anick BérardHedvig Nordeng
Sep 2, 2008·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Benjamin Bar-OzAsher Ornoy
Sep 25, 2007·Best Practice & Research. Clinical Gastroenterology·Uma Mahadevan
Jun 10, 2008·Anatomia, histologia, embryologia·A K KarabulutZ Fazliogullari
Aug 31, 2007·Pharmacoepidemiology and Drug Safety·J Alexander ColeAlexander M Walker
Aug 10, 2006·Pharmacoepidemiology and Drug Safety·J Alexander ColeAlexander M Walker
Apr 3, 2012·British Journal of Clinical Pharmacology·Maria RomørenHedvig Nordeng
Feb 13, 2007·Travel Medicine and Infectious Disease·I Dale Carroll, Alfons Van Gompel
Jul 29, 2004·Disease-a-month : DM·Noah S ScheinfeldJeffrey M Weinberg
Nov 26, 2015·Pharmacotherapy·P Brandon BookstaverMilena McLaughlin
Feb 25, 2011·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Jianzhou YangShi Wu Wen
Jan 30, 2015·Pharmacoepidemiology and Drug Safety·Andrea V MargulisSonia Hernández-Díaz
Aug 20, 2004·Annales de dermatologie et de vénéréologie·A Henno, M De La Brassinne

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.